Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges

Area of Science:

• Neuroimmunology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Multiple sclerosis (MS) is a chronic CNS autoimmune disease causing inflammation, demyelination, and neurodegeneration.
• Current MS treatments focus on immune modulation but do not halt disease progression or reverse CNS damage.
• Mesenchymal stem cells (MSCs) present a potential therapeutic strategy due to their immunomodulatory, neuroprotective, and regenerative properties.

Purpose of the Study:

• To analyze the mechanisms of action of MSC therapy in MS.
• To review preclinical and clinical evidence on MSC efficacy and safety for various MS phenotypes.
• To identify challenges and future directions for MSC-based MS treatments.

Main Methods:

• Review of preclinical studies and clinical trials on MSC therapy for MS.
• Analysis of MSC mechanisms including immune regulation, remyelination, and neuroregeneration.
• Examination of delivery routes, dosing, and combination strategies for MSCs in MS.

Main Results:

• MSCs demonstrate immunomodulatory, neuroprotective, and regenerative effects relevant to MS pathology.
• Preclinical and clinical data suggest potential efficacy and safety of MSC therapy across MS types.
• Challenges remain in optimizing delivery, dosage, and integration with existing therapies.

Conclusions:

• MSC therapy holds significant promise for revolutionizing multiple sclerosis treatment.
• Further research and clinical trials are essential to overcome current limitations.
• Personalized and combinatory MSC approaches may offer improved outcomes for MS patients.